The Effect of Low-dose Empagliflozin on Glucose Control in Adult Patients With Type 1 Diabetes on a Closed-loop Insulin System: a Randomized Cross-over Controlled Trial
Latest Information Update: 13 Oct 2022
At a glance
- Drugs Empagliflozin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms CL-LoDE
Most Recent Events
- 06 Oct 2022 Status changed from recruiting to completed.
- 02 Nov 2020 Status changed from not yet recruiting to recruiting.
- 01 Jul 2020 New trial record